0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-08-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09648830 2024-08-01 2025-07-31 09648830 2025-07-31 09648830 2024-07-31 09648830 2023-07-01 2024-07-31 09648830 2024-07-31 09648830 2023-06-30 09648830 bus:Director1 2024-08-01 2025-07-31 09648830 core:WithinOneYear 2025-07-31 09648830 core:WithinOneYear 2024-07-31 09648830 core:ShareCapital 2025-07-31 09648830 core:ShareCapital 2024-07-31 09648830 core:RetainedEarningsAccumulatedLosses 2025-07-31 09648830 core:RetainedEarningsAccumulatedLosses 2024-07-31 09648830 core:CostValuation core:Non-currentFinancialInstruments 2025-07-31 09648830 core:Non-currentFinancialInstruments 2025-07-31 09648830 core:Non-currentFinancialInstruments 2024-07-31 09648830 bus:SmallEntities 2024-08-01 2025-07-31 09648830 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09648830 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09648830 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09648830 bus:AbridgedAccounts 2024-08-01 2025-07-31
COMPANY REGISTRATION NUMBER: 09648830

Abaly International Limited

Filleted Unaudited Abridged Financial Statements

31 July 2025

Abaly International Limited

Abridged Statement of Financial Position

31 July 2025

| 2025 | 2024
Note | £ | £ | £

Fixed assets

Investments | 4 |  | 100 | 100

Current assets

Debtors | 244,051 |  | 2,019,974

Creditors: amounts falling due within one year | 477,390 |  | 1,104,548
| --------- |  | ------------
Net current (liabilities)/assets |  | ( 233,339) | 915,426
|  | --------- | ---------
Total assets less current liabilities |  | ( 233,239) | 915,526
|  | --------- | ---------
Net (liabilities)/assets |  | ( 233,239) | 915,526
|  | --------- | ---------

Capital and reserves

Called up share capital |  | 1,000 | 1,000
Profit and loss account |  | ( 234,239) | 914,526
|  | --------- | ---------
Shareholders (deficit)/funds |  | ( 233,239) | 915,526
|  | --------- | ---------

These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 July 2025 in accordance with Section 444(2A) of the Companies Act 2006.

Abaly International Limited

Abridged Statement of Financial Position (continued)

31 July 2025
These abridged financial statements were approved by the board of directors and authorised for issue on 30 March 2026 , and are signed on behalf of the board by:

Mr N Abdelsaid |
Director |

Company registration number: 09648830

Abaly International Limited

Notes to the Abridged Financial Statements

Year ended 31 July 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 97 B Fulham Road, London, W6 8JA, England.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.
4. Investments

| £
Cost |
At 1 August 2024 and 31 July 2025 | 100
| ----
Impairment |
At 1 August 2024 and 31 July 2025 | –
| ----
Carrying amount |
At 31 July 2025 | 100
| ----
At 31 July 2024 | 100
| ----

5. Directors' advances, credits and guarantees
At the year end the company owed the directors £477,029 (2024: £1,089,029).
6. Related party transactions
The company was under the control of the directors throughout the current and previous year.